Navigation Links
Markets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015
Date:11/5/2012

FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion.

(Photo: http://photos.prnewswire.com/prnh/20121105/CG06410

From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research partner BioPharm Reports,, is offering a special discount on all BioPharm market research reports, forecasts, and studies. How will your organization use the critical information contained within these reports to support growth and sales strategies and seize market opportunities in the life sciences field?

Life Science Software: Markets and Opportunities

This report is the result of six life science studies examining the use of specialist software and databases related to the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. In total, 2,200 end-users in 70 countries participated in these studies. This is an excellent study for software developers and vendors to identify market opportunities in the life science field.

The major components of the report are as follows: breakdown of end-user practices in use of life science software and databases to conduct studies of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry, and disease biomarker; breakdown of end-user practices by field (e.g. biotech, hospital, defence, pharmaceuticals, food and drink); breakdown by region, including Europe, North America, Asia and RoW countries; list of participating organizations and anticipated growth; and estimates of global market sizes of software and databases related to the respective life science fields.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph251023-life-science-software-markets-opportunities.html

DNA Microarray 2012: A Focus on Sales Growth

Based on the prevailing and emerging market conditions in the DNA microarray field, this report was created to assist marketing and sales with the identification of new opportunities. The analysis and report findings provide a "focus on sales growth" to developers and vendors in the microarray field and the changes driving these developments.

Market areas covered in this study include: routine use, suppliers, methods, applications, preferred companies, products, strengths, weaknesses, financial budgets, budget breakdown, future budget breakdown, future budgets, consumables, quality control, challenges, innovation, recent innovations, future innovation, biomarkers, organizations, fields, bioinformatics software, purpose, samples and sample preparation.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph250862-dna-microarray-focus-on-sales-growth.html

Life Science Consumables: Markets and Opportunities

Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. This report identifies the markets and opportunities within the life science consumables field related to PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarkers.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bph251024-life-science-consumables-markets-opportunities.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
2. The International Society for Advancement of Cytometry presented its 2012 awards at CYTO 2012
3. Costs for changing pollution criteria in Florida waters likely to exceed EPA estimates
4. Natures billion-year-old battery key to storing energy
5. MEMS Market Triples 2009-2011, to Reach $5.4 Billion in 2017
6. Palladium-gold nanoparticles clean TCE a billion times faster than iron filings
7. Global Biobanking Market Projected to Increase by 30% to Reach $183 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... engineers, and scientists from around the world, was today awarded the "Best Science ... is based entirely on merit and decided upon by a dedicated team of ...
(Date:1/19/2017)... -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. ... and inoperable solid tumor cancers, announced today that Dr. ... Bio, will present at the Phacilitate Immunotherapy World Conference ... Hotel in Miami, Florida . ... Therapeutic Approaches – Expanding the Reach of Cancer Immunotherapy ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 According to ... Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, ... market is expected to reach USD 739.9 Million by 2021 from USD 557.1 ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology Technology: